Boston Life Science Inventory Up 29% in 3 Years, Ranked #1 for Growth
Life Science real estate has been on a clip of fast expansion, fueled by the increased investor attention and heightened space demand the sector experienced in the wake of the …
Boston Biotech
Newer Life Science Properties Driving Occupancy Losses Across the Sector
The US Life Science or Biotech real estate sector has seen tremendous growth during the past 3 years. Overall, since 2Q22, the US Life Science sector has grown by 17% to 401 million square feet (MSF) in 2Q25.
Oversupply Presents Opportunity for Established Pharma
With many state-of-the-art, brand-new research facilities sitting empty across major research clusters in the U.S., established pharmaceutical and biotechnology firms have an opportunity to secure ideal spaces in prime locations. …
New Deliveries, Older Properties Most Impacted by Oversupply
Last year Life Science inventory in the top 3 clusters, Boston, San Francisco & San Diego, grew by over 10%. With this incredible growth, combined with softer space demand, many …
Established Micro Clusters More Insulated from Market Cycles
With a significant amount of new inventory entering the market and weaker demand for space due to the volatile funding environment, the top three life science real estate markets—Boston, San …
4th Quarter Life Science Real Estate Update – Slides and Webinar
RevistaLab.com recently held its 4th quarter life science real estate update. Revista principals, Hilda Martin and Mike Hargrave presented RevistaLab data on construction trends, transactions, occupancies, supply/demand fundamentals across the …
See the Top Ten Boston Life Science Developers
Boston is the center of the US Life Science universe, and it has been even more of a focal point for the investment community in the past few years. Not …